题名 | miR-340-FHL2 axis inhibits cell growth and metastasis in ovarian cancer |
作者 | |
发表日期 | 2019-05-08 |
发表期刊 | CELL DEATH & DISEASE 影响因子和分区 |
语种 | 英语 |
原始文献类型 | Article |
其他关键词 | EPITHELIAL-MESENCHYMAL TRANSITION ; PROTEIN FHL2 ; SCAFFOLD PROTEIN ; DNA METHYLATION ; BETA-CATENIN ; TUMOR-GROWTH ; EXPRESSION ; INTERACTS ; MICRORNAS ; DIFFERENTIATION |
摘要 | Although increasing evidence indicated that deregulation of microRNAs (miRNAs) contributed to tumor initiation and progression, but little is known about the biological role of miR-340 in ovarian cancer (OC). In this study, we found that miR-340 expression was downregulated in OC tissues compared with its expression in normal ovarian epithelium and endometrium, and treatment with 5-aza-2'-deoxycytidine (5-Aza-dC) or trichostatin A (TSA) increased miR-340 expression in OC cells. In addition, ectopic miR-340 expression inhibited OC cell growth and metastasis in vitro and in vivo. Four and a half LIM domains protein 2 (FHL2) was confirmed as a direct target of miR-340 and silencing FHL2 mimicked the effects of miR-340 in OC cells. Further mechanistic study showed that miR-340 inhibited the Wnt/beta-catenin pathway by targeting FHL2, as well as downstream cell cycle and epithelial-to-mesenchymal transition (EMT) signals in OC cells. Moreover, the greatest association between miR-340 and FHL2 was found in 481 ovarian serous cystadenocarcinoma tissues via pan-cancer analysis. Finally, we revealed that lower miR-340 or higher FHL2 was associated with poor OC patient outcomes. Our findings indicate that the miR-340-FHL2 axis regulates Wnt/beta-catenin signaling and is involved in tumorigenesis in OC. Therefore, manipulating the expression of miR-340 or its target genes is a potential strategy in OC therapy. |
资助项目 | National Natural Sciences Foundation of ChinaNational Natural Science Foundation of China (NSFC) [NSFC-81472651, 81201589] |
出版者 | NATURE PUBLISHING GROUP |
出版地 | LONDON |
ISSN | 2041-4889 |
卷号 | 10期号:5页码:372 |
DOI | 10.1038/s41419-019-1604-3 |
页数 | 16 |
WOS类目 | Cell Biology |
WOS研究方向 | Cell Biology |
WOS记录号 | WOS:000468670100006 |
收录类别 | SCIE ; PUBMED ; SCOPUS |
URL | 查看原文 |
PubMed ID | 31068580 |
PMC记录号 | PMC6506554 |
SCOPUSEID | 2-s2.0-85065442875 |
通讯作者地址 | [Wu, Jianmin]Institute of Genomic Medicine,Wenzhou Medical University,Wenzhou,325000,China |
Scopus学科分类 | Immunology;Cellular and Molecular Neuroscience;Cell Biology;Cancer Research |
TOP期刊 | TOP期刊 |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | https://kms.wmu.edu.cn/handle/3ETUA0LF/12258 |
专题 | 基因组医学研究院 附属第二医院 第二临床医学院、附属第二医院、育英儿童医院_妇产科学 附属第二医院_妇产科 |
通讯作者 | Wu, Jianmin |
作者单位 | 1.Institute of Genomic Medicine,Wenzhou Medical University,Wenzhou,325000,China; 2.Department of Obstetrics and Gynecology,The Second Affiliated Hospital and Yuying Children of Wenzhou Medical University,Wenzhou,325027,China |
第一作者单位 | 基因组医学研究院 |
通讯作者单位 | 基因组医学研究院 |
第一作者的第一单位 | 基因组医学研究院 |
推荐引用方式 GB/T 7714 | Huang, Zheng,Li, Qiuxia,Luo, Kaili,et al. miR-340-FHL2 axis inhibits cell growth and metastasis in ovarian cancer[J]. CELL DEATH & DISEASE,2019,10(5):372. |
APA | Huang, Zheng., Li, Qiuxia., Luo, Kaili., Zhang, Qinkai., Geng, Jingwen., ... & Wu, Jianmin. (2019). miR-340-FHL2 axis inhibits cell growth and metastasis in ovarian cancer. CELL DEATH & DISEASE, 10(5), 372. |
MLA | Huang, Zheng,et al."miR-340-FHL2 axis inhibits cell growth and metastasis in ovarian cancer".CELL DEATH & DISEASE 10.5(2019):372. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论